In more recent studies, Annexin V binding to CD8+ T cells in patients with HNSCC was found to be a less sensitive endpoint in discriminating patients from controls than the frequency of circulating CD8+ CCR7+ T cells, as discussed below (Czystowska et al., 2012). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.